TickerFactsScreenerDevelopers

GALECTIN THERAPEUTICS INC (GALT) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: -$4.47M2010: -$1.69M2011: -$2.12M2012: $1.17M2013: $1.48M2014: $21.20M2015: $18.04M2016: $10.29M2017: -$530.0K2018: $5.17M2019: $43.87M2020: $22.47M2021: $893.0K2022: -$33.92M2023: -$61.96M2024: -$104.79M2025: -$127.92M-$127.92M
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$127.92M-22.1%
2024-$104.79M-69.1%
2023-$61.96M-82.7%
2022-$33.92M-3898.1%
2021$893.0K-96.0%
2020$22.47M-48.8%
2019$43.87M+747.8%
2018$5.17M+1076.4%
2017-$530.0K-105.1%
2016$10.29M-42.9%
2015$18.04M-14.9%
2014$21.20M+1331.1%
2013$1.48M+27.1%
2012$1.17M+154.8%
2011-$2.12M-25.4%
2010-$1.69M+62.1%
2009-$4.47M—